bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.09.750350

Accurate and scalable decontamination of imaging-based spatial transcriptomics via optimal transport

Abstract

Imaging-based spatial transcriptomics enables molecule-resolved profiling of gene expression and tissue organization in situ. However, segmentation errors, transcript spillover and three-dimensional cell overlap can introduce misassigned transcripts into cell-level expression profiles, compromising biological interpretation and obscuring genuine signals. Existing methods either remove suspect expression at the cost of signal loss or lack a biologically grounded criterion for transcript assignment. Here we present CellDot, an optimal-transport framework that determines the fate of each transcript by retaining it in its host cell, reassigning it to a plausible neighboring cell or removing it as background. By integrating reference-guided expression compatibility with spatial information and data-adaptive constraints, CellDot enables accurate and traceable molecule-level correction while preserving biologically meaningful variation. In evaluations across multiple human tumor datasets, CellDot exhibited superior performance compared to existing decontamination methods, successfully restoring spatial expression patterns that matched independent cross-platform measurements. Moreover, it significantly enhanced the recovery of cellular states, intercellular communication, and spatial niche programs. Our experiments using real data demonstrated CellDot's scalability and established it as the only method applicable to a whole-transcriptome Atera dataset, underscoring its distinct advantages in the field of spatial transcriptomics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chen, Y., Liu, Y., Chao, Z., Han, S., Zeng, Y., Yu, B., Zhang, F., Wu, A., Wang, J., Chen, H., Xiao, J., Yang, C.. 2026-09-15. Accurate and scalable decontamination of imaging-based spatial transcriptomics via optimal transport. https://doi.org/10.64898/2026.09.09.750350

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Accounting for pseudo-replication of Linkage Disequilibrium for contemporary Ne estimation

The Linkage Disequilibrium (LD) of unlinked loci can be used to estimate contemporary effective population size (Ne) of one to a few generations ago. In genomic datasets loci on different chromosomes are considered unlinked, but there are many more pairs of unlinked loci than there are independent pairs of chromosomes, resulting to confidence intervals (C.I.) being too narrow if the non-independence is not taken into account. Simulations were run to investigate the correlation structure among LD of unlinked loci, which can be expressed by the LD of loci along the same chromosomes, based on a discovery of a novel Random Probe LD estimator. We classify the correlation into two categories: overlapping of loci and disjoint pairs. The former is induced from the same locus being considered twice and is the stronger form of correlation. These correlations feed into {rho}, a parameter to quantify the degree of pseudo-replication in a dataset, and further a correction formula from which C.I. can be properly inferred. We demonstrate the use of our method via an analysis of genomic data from the malaria-transmitting Anopheles gambiae s.s mosquitoes. Apart from the point and C.I. estimates, we find that Var((r^2 ) ) is inflated by about 550 times due to pseudo-replication, highlighting the danger of not handling genetic correlation properly.

bioinformatics↗

Interpretable Machine Learning Reveals Complementary Age-Related Signatures in the Oral and Gut Microbiome

Whether combining microbiome data from multiple body sites improves prediction, and whether different sites carry complementary or redundant information, are distinct questions that most studies conflate into a single accuracy metric. This work makes two contributions, one methodological and one biological, using paired stool and oral cavity microbiome samples from 44 subjects across two age groups, healthy adults and newborns (Ferretti et al., 2018). Methodologically, we show that a subject-matched fusion design combined with SHAP-based (SHapley Additive exPlanations) site attribution can detect complementary information between body sites even when no measurable accuracy gain results. This is a pattern that conventional model comparison would misread as a null result. Gut (stool) composition alone achieved near-perfect classification (area under the receiver operating characteristic curve, AUC = 1.00), and combined stool-oral models never exceeded this ceiling. A null baseline, bootstrap confidence intervals, and preprocessing sensitivity checks confirmed that this ceiling reflects genuine biological signal rather than an artifact. Despite the flat accuracy curve, SHAP analysis of the fused model showed that oral cavity features carried more total feature importance than stool features (58.1% versus 41.9%), indicating that the model draws on real, non-redundant information from both sites. Biologically, the taxa driving this pattern include Malassezia restricta, Staphylococcus epidermidis, and Prevotella melaninogenica. These taxa behave in a manner consistent with their established roles as early colonizers of the neonatal gut, skin, and oral cavity, once their model-specific behavior is verified directly against abundance data rather than inferred from the literature alone. An independent, substantially larger paired-cohort study using a different analytical method reports a compatible pattern. Together, these results support a model of oral-gut microbiome maturation as two distinct, complementary processes, and demonstrate that detecting this kind of relationship requires examining a model's internal reasoning rather than its accuracy alone.

bioinformatics↗

ReverseScreen.ai: Pharmacophore-Guided Reverse Screening Across the Growing Co-Complex Proteome

Biopharmaceutical companies routinely use forward screening to identify potential ligands for targets of biological consequence. Increasingly, they are also using reverse screening to proactively identify downstream off-target liabilities and new repurposing opportunities. Exhaustive reverse docking of one or a multitude of molecules across every characterized site is one approach, but the computational cost is often prohibitive. One molecule against 28,579 receptor sites takes 40.5 hours on twenty CPU cores. We present a method that puts a retrieval step in front of the docking. Every co-crystallized ligand in the Protein Data Bank is indexed by the 3-dimensional pharmacophore fingerprint it presents, together with the UniProt accessions it was solved against, and a query retrieves the sites belonging to its nearest neighbors. Fingerprints are predicted from two-dimensional structures with PharmCast, so a query is fingerprinted in 4 ms and searched against 27,797 indexed ligands in 40 ms. For a query molecule we take its 5 most similar indexed ligands and pool every protein those 5 were crystallized with, which averages 21.1 distinct proteins. Across 3,000 held-out molecules that pool contained the molecule's own known target 48.8 percent of the time. Docking those 21.1 proteins takes 108 s, against 40.5 hours for the full panel. Pooling the twenty-five most similar ligands instead gives 104.5 proteins and finds the target 60.8 percent of the time. To be indexed, a structure only has to establish which ligand sat in which protein. Holding the index to pocket-grade coordinates had been excluding whole receptor classes. Admitting X-ray at 2.5 [A] and cryo-EM at 4.0 [A] takes coverage from 3,670 target sites to 28,579. Two 2025 clinical molecules were cross-validated. Orforglipron returned the glucagon-like peptide 1 (GLP-1) receptor first of 27,797 ligands, through a non-identical analog at 0.901; daraxonrasib returned the KRAS and cyclophilin A tri-complex fourth, at 0.836. When run in batches the pipeline reverse screens about 96,000 molecules per hour on 1 core, roughly 2.3 million per day, so the retrieval step is practical even with a massive virtual library. The method is available at reversescreen.ai, which allows users the opportunity to screen molecules against the current index, returns the retrieved sites, and docks them individually. The index itself can be downloaded for confidential screening in a local environment. Keywords: reverse screening, target identification, pharmacophore fingerprint, molecular docking, polypharmacology, off-target prediction, virtual screening, repurposing

bioinformatics↗